Koninklijke Philips Nv
PHG NYSE· X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Last close · Oct 30, 2026
$26.92
KIRA · Stoqly’s AI analyst, in plain words
- Koninklijke Philips Nv had $20.1B of revenue in fiscal 2025, up 3.2% on the year before. Over five years, revenue changed +0.4% a year on average.
- Its operating margin was 8.0%, up 5.0 pts: of every 100 in sales, about 8 is left after running the business.
- Koninklijke Philips Nv made $1.0B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −5.4% a year.
- Koninklijke Philips Nv returned $370M to shareholders in fiscal 2025. The diluted share count rose 3.1%.
- Koninklijke Philips Nv owes $6.2B more than it holds in cash, about 2.2 years of operating profit.
Market cap
$25.9B
P/E
25.7x
Revenue
$20.1B
Net income
$1.0B
Free cash flow
—
Operating margin
8.0%
Koninklijke Philips Nv in 30 seconds · fiscal 2025
Are sales growing?
+3.2%
Only a little. Sales grew 3.2% last year.
Does it make a profit?
5.0%
A little. It keeps 5.0% of every sale as profit.
Is debt under control?
2.2x
Keep an eye on it. Repaying its debt would take 2.2 years of operating profit.
How healthy are the accounts?
4 / 7
Mixed. It passes 4 of 7 health tests.
How is the share priced?
25.7x
One share costs 25.7 times its yearly profit per share.
What Koninklijke Philips Nv does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Feb 19, 2026
- Legal name
- KONINKLIJKE PHILIPS NV
- CIK
- 0000313216
Koninklijke Philips Nv · PHG · stoqly.net
Results and finances
The last 5 fiscal years. Amounts in USD. Compiled by stoqly.net.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $20.3B | $18.7B | $19.6B | $19.5B | $20.1B |
| Revenue growth | 2.8% | −7.7% | 4.9% | −0.8% | 3.2% |
| Gross margin | 41.8% | 40.4% | 41.0% | 43.1% | 45.2% |
| Operating margin | 3.2% | −8.6% | −0.6% | 2.9% | 8.0% |
| Net income | $3.9B | −$1.7B | −$504M | −$759M | $1.0B |
| Net margin | 19.3% | −9.0% | −2.6% | −3.9% | 5.0% |
| Diluted EPS | $4.14 | −$1.78 | −$0.53 | −$0.81 | $1.05 |
| Cash | |||||
| Capital expenditure | $470M | $467M | $373M | $343M | $303M |
| Dividends paid | $570M | $433M | $2.2M | $1.1M | $370M |
| Share buybacks | $1.9B | $197M | $716M | $445M | $0.0M |
| Share count change | 4.0% | 0.9% | −0.4% | −1.6% | 3.1% |
| Debt and strength | |||||
| Cash and short-term investments | $2.6B | $1.3B | $2.1B | $2.5B | $3.3B |
| Debt incl. finance leases | $7.9B | $8.7B | $8.5B | $7.9B | $9.5B |
| Shareholders' equity | $16.4B | $14.1B | $13.3B | $12.5B | $12.9B |
| Net debt / EBITDA | 2.4x | 97.7x | 5.2x | 2.6x | 2.2x |
| Current ratio | 1.4x | 1.3x | 1.2x | 1.2x | 1.3x |
| Interest coverage | 3.5x | −6.5x | −0.4x | 1.8x | 4.9x |
| Returns and quality | |||||
| Return on capital | 3.0% | −5.9% | −0.5% | 2.1% | 6.4% |
| Return on equity | 25.4% | −11.1% | −3.7% | −5.9% | 8.0% |
| Return on tangible equity | 2,295.2% | — | — | — | — |
| Piotroski F-score | 3 | 0 | 5 | 4 | 4 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Koninklijke Philips Nv · PHG · stoqly.net
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $26.92 a share, the company is worth $25.9B: 25.7 times its earnings of the last four quarters.
Compiled and analysed by stoqly.net from SEC EDGAR XBRL filings (CIK 0000313216). Latest version: stoqly.net/companies/phg. Data updated November 1, 2026. Filed in EUR under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.